Clinical trial
Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
NCT00267865 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00267865 |
|---|---|
| Title | Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma |
| Official title | AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AIDS-Related-Primary Central Nervous System Lymphoma |
| Intervention type | Drug |
| Interventions | Methotrexate, Rituximab, Leucovorin |
| Enrollment | 12 |
| Start date | Sep 14, 2006 |
| Primary completion | Sep 18, 2019 |
| Completion | Sep 19, 2019 |
| First posted | Dec 21, 2005 |
| Last update posted | Jun 1, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: